Advertisement

Topics

Pherin Corporationoration Company Profile

09:14 EST 17th December 2018 | BioPortfolio

Pherin Pharmaceuticals, Inc. is focused on the discovery and development of a new family of pharmaceutical compounds called vomeropherins. Vomeropherins have the ability to non-invasively activate specific chemoreceptors found in a structure known as the vomeronasal organ (VNO), which is located in the nasal passage (see diagram). The VNO sends neural impulses directly to the hypothalamus, a key regulatory control center of the brain. Based upon its proprietary technology and its research findings to date, the Company is strongly positioned to develop a portfolio of vomeropherin-based therapies that are superior to existing medications for the treatment of various disorders of the central nervous system (CNS) and the endocrine system because they (i) act very rapidly, (ii) are effective in very small dosages, (iii) do not require systemic absorption in order to exert their effects, (iv) are delivered easily and non-invasively, and (v) have an excellent safety profile.

Location

350 N. Bernardo Avenue
Mountain View
CA
94043
United States of America

Contact

Phone: (650) 903-7100
Fax: (650) 903-7101
Email: dlb@pherin.com


News Articles [5 Associated News Articles listed on BioPortfolio]

VistaGen gains exclusive license to Pherin's PH94B anxiety compound, options PH10 for MDD

VistaGen Therapeutics Inc. licensed exclusive worldwide development and commercialization rights to Pherin Pharmaceuticals Inc.'s PH94B (aloradine) nasal spray in Phase III for social anxiety disorder...

VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals

VistaGen Therapeutics (NASDAQ:VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) diseases and disor...

VistaGen Therapeutics Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder

Phase 3-ready asset expands VistaGen’s CNS pipeline and complements its neuropsychiatry focus on Major Depressive Disorder (MDD) with AV-101 Novel PH94B nasal spray expected to enter pivotal Phase...

$VTGN Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder https://finance.yahoo.com/news/vistagen-therapeutics-acquires-worldwide-license-123000078.html …

$VTGN Acquires Worldwide License of Phase 3-Ready CNS Drug Candidate from Pherin Pharmaceuticals for As-Needed Treatment of Social Anxiety Disorder https://finance.yahoo.com/news/vistagen-therapeuti...

VistaGen Therapeutics Acquires Worldwide Rights to Develop and Commercialize PH10

VistaGen Therapeutics (NASDAQ:VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system diseases and disorders with high unmet need, today annou...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Pherin Corporationoration

Pherin Pharmaceuticals, Inc. is focused on the discovery and development of a new family of pharmaceutical compounds called vomeropherins. Vomeropherins have the ability to non-invasively activate spe...

Pherin Pharmaceuticals, Inc.

Pherin Pharmaceuticals, Inc. (the “Company”), a privately held company headquartered in Redwood City, California, USA, started operations in 1991.Vomeropherins Represent a New Class of Pharmaceuti...

More Information about "Pherin Corporationoration" on BioPortfolio

We have published hundreds of Pherin Corporationoration news stories on BioPortfolio along with dozens of Pherin Corporationoration Clinical Trials and PubMed Articles about Pherin Corporationoration for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pherin Corporationoration Companies in our database. You can also find out about relevant Pherin Corporationoration Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Endocrine Disorders
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record